Practices can delabel other suspected drug allergies while assessing patients for allergies to COVID-19 vaccines, according to a study published in Vaccine. This program can improve health-related ...

Discover a study that supports integrating direct single-dose drug provocation test into routine clinical practice for ...

Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a ...

Resumption of dosing in this study triggers a $10M milestone payment from GSK plus an additional $20M milestone due in six months; as previously disclosed GSK disputes these milestone payments, and ...

While gaps persist in workforce retention, infrastructure, and equitable access, the transformation of Nigeria’s health ...

beta and non-beta lactam tablets and capsules and nutritional food supplements. Its products include cardiovascular drugs, musculoskeletal drugs, antibiotic drugs, central nervous system drugs ...

Patients with a label of ‘multiple antibiotic allergy’. Patients with a history of immediate or non-immediate* reaction to penicillin ... cephalosporin/s requiring specific treatment with a ...

Key themes and highlights from ESCMID Global 2025 to support antimicrobial stewardship and best practice in infectious ...

Cefazolin is safe for surgical site infection prophylaxis in orthopedic procedures for patients with beta-lactam allergies, a ...

These findings bolster existing clinical sentiment that once MSSA is confirmed, β-lactam agents, such as nafcillin or ...

The beta-lactam antibiotic penicillin represents one of the predominantly used antibiotics for the treatment of infectious diseases. It is produced as an end product by certain filamentous fungi ...